Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
3.180
-0.200 (-5.92%)
At close: Sep 9, 2026, 4:00 PM EDT
3.140
-0.040 (-1.26%)
Pre-market: Sep 10, 2026, 7:10 AM EDT
Beyond Air Revenue
Beyond Air had revenue of $1.77M in the quarter ending June 30, 2026, with 0.45% growth. This brings the company's revenue in the last twelve months to $7.69M, up 60.75% year-over-year. In the fiscal year ending March 31, 2026, Beyond Air had annual revenue of $7.68M with 107.26% growth.
Revenue (ttm)
$7.69M
Revenue Growth
+60.75%
P/S Ratio
0.40
Revenue / Employee
$142,352
Employees
54
Market Cap
3.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.68M | 3.97M | 107.26% |
| Mar 31, 2025 | 3.71M | 2.55M | 219.67% |
| Mar 31, 2024 | 1.16M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 873.00K | -517.10K | -37.20% |
| Mar 31, 2020 | 1.39M | -6.33M | -82.00% |
| Mar 31, 2019 | 7.72M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| INVO Fertility | 7.53M |
| Tenon Medical | 5.31M |
| VolitionRx | 2.46M |
| ENvue Medical | 1.93M |
| Catheter Precision | 1.92M |
XAIR News
- 8 days ago - Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference - GlobeNewsWire
- 9 days ago - Beyond Air initiated with a Buy at Lake Street on durable recurring revenue - TheFly
- 9 days ago - Beyond Air initiated with a Buy at Lake Street - TheFly
- 10 days ago - Beyond Air gets Breakthrough Device Designation for LungFit GO - TheFly
- 10 days ago - Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - GlobeNewsWire
- 16 days ago - Beyond Air to sell NeuroNOS stake to Univo Pharmaceutical - TheFly
- 16 days ago - Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - GlobeNewsWire
- 23 days ago - Beyond Air files to sell 5.42M shares of common stock for holders - TheFly